Normalcy will approach when we can manufacture our own medical supplies again.
And not before.
This isn’t just about the kung flu.
It’s about first world economies that created a communist country as their single point of failure. For most every product, not just medical supplies.
Remember when Joementia Biden said China wasn’t a threat to us and he called POTUS Trump a Racist for implementing the China Travel Ban?
Hopefully the Trump Reelection Campaign will include those golden oldies in all their Commercials.
This is about distribution, not manufacturing. We could have all kinds of products coming out of US factories but distributors like Amazon would still need to shift priorities to put medical supplies ahead of DVDs.
But I agree that this crisis will accelerate the decoupling of the US economy from China’s which is long overdue but which few thought would actually happen. How would President Trump have convinced a pharma company to move manufacturing from China back to the US three months ago? Now, it’s a completely different story. It never should have happened, but that’s how things work in a free society. However now the pendulum will swing back. Not just under it’s own power, it will be pulled back.
From another thread: "Media is spreading the word that we import a lot of our drugs from China. We do not. We do import a lot of the medical supplies and paraphernalia, such as gloves, masks, gowns, etc., which we can make ourselves."
[Begin quote] From Investopedia (2017) Who Supplies America’s Drugs?
Ireland, Germany, Switzerland, Israel, and India are the top five drug suppliers to the US, in the decreasing order of import dollar value.
More than 52% of imported drugs were from the first four countries, none of which qualifies for a low-cost or cheap-labor destination.
Ireland, Germany, Switzerland and Israel focus on research-based pharmaceutical development. Only India, with around 7% of contribution to the U.S. drug imports, is a low-cost economy offering labor cost arbitrage. It indicates that U.S. mainly imports drugs that are innovative and research-oriented, rather than those which offer cost advantage.
Ireland holds the top rank, with around $15.2 billion worth of drug exports to the U.S., constituting 18% of the total U.S. drug imports of 2015. It is closely followed by Germany with $14.5 billion, or around 17%. Another European nation, Switzerland, supplied $9.4 billion worth of drugs, representing around 11% contribution. Israel stands fourth at $6 billion, at par with Indian exports to U.S.
[End quote]